Durvalumab vs Oseltamivir

Durvalumab vs Oseltamivir: Overview

This comparison examines the pharmacological differences between Durvalumab and Oseltamivir.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Oseltamivir: Neuraminidase inhibitor preventing viral release from host cells.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Oseltamivir — 6-10 hours.

Chemical Properties

Molecular Formula: Oseltamivir — C16H28N2O4.

Molecular Weight: Oseltamivir — 312.4050 g/mol.

Type: Durvalumab — Antibody; Oseltamivir — Small molecule.